These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 11763553

  • 1. [Effectiveness of the standard mode of chemotherapy for newly-diagnosed patients with destructive pulmonary tuberculosis with bacterial isolation].
    Mishin VIu, Chukanov VI, Vylegzhanin SV.
    Probl Tuberk; 2001; (7):13-8. PubMed ID: 11763553
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].
    Mishin VIu, Chukanov VI, Vasil'eva IA.
    Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Efficiency of a new standard chemotherapy regimen in the treatment of patients with recurrent pulmonary tuberculosis].
    Chukanov VI, Komissarova OG, Maishin VIu, Abdullaev RIu, Kononets AS.
    Probl Tuberk Bolezn Legk; 2006 Oct; (8):9-13. PubMed ID: 17002050
    [Abstract] [Full Text] [Related]

  • 7. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR.
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW, Abate G, Lakew M, Goshu S, Aseffa A.
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D, Seyoum B, Makonnen E, Atsebeha H, Woldemeskel D, Yamuah L, Addus H, Aseffa A.
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Diagnosis and treatment of acute progressive tuberculosis types].
    Khomenko AG, Mishin VI.
    Probl Tuberk; 1996 Oct; (5):21-3. PubMed ID: 8984482
    [Abstract] [Full Text] [Related]

  • 16. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II, Shmelev EI.
    Probl Tuberk Bolezn Legk; 2004 Oct; (7):32-5. PubMed ID: 15379039
    [Abstract] [Full Text] [Related]

  • 17. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.